[Cellular differential impact of the Rap1 on atherosclerosis]

Shan-Shan Song1, Hui-Ru Yang1, Xiao-Li Yi1

  • 1Translational Medicine Centre, Jiangxi University of Chinese Medicine, Nanchang 330004, China.

Insights

Cardiovascular diseases, including atherosclerosis, are major health threats. This study explores how Ras-association proximate 1 (Rap1) may influence atherosclerosis development, offering potential new therapeutic targets.

Area of Science:

  • Cardiovascular biology
  • Molecular cell biology
  • Biochemistry

Background:

  • Cardiovascular diseases (CVDs) are the leading cause of mortality globally.
  • Atherosclerosis, a chronic inflammatory condition, underlies most CVDs, yet its pathogenesis remains incompletely understood.
  • Ras-association proximate 1 (Rap1) is a small GTPase regulating crucial cellular processes like differentiation, proliferation, and adhesion.

Purpose of the Study:

  • To summarize the potential role and mechanisms of Rap1 in atherosclerosis progression.
  • To investigate Rap1's cell-specific influence on atherosclerosis development.
  • To identify novel therapeutic targets for clinical intervention in atherosclerosis.

Main Methods:

  • Literature review and synthesis of existing research on Rap1 signaling pathways.
  • Analysis of cell-specific functions of Rap1 in the context of atherosclerosis.
  • Exploration of molecular mechanisms underlying Rap1's involvement in atherogenesis.

Main Results:

  • Rap1 acts as a molecular switch, cycling between Rap1-GTP and Rap1-GDP states.
  • Rap1's influence on atherosclerosis is likely cell-specific.
  • Understanding Rap1's function provides insights into atherogenesis.

Conclusions:

  • Rap1 signaling pathways represent a promising area for therapeutic strategies against atherosclerosis.
  • Targeting Rap1 could offer novel clinical interventions for cardiovascular diseases.
  • Further research into Rap1's cell-specific roles is warranted to fully elucidate its impact on atherosclerosis.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
93
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
42
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
69